Biallelic loss of function (LOF) mutations in RIPK1 cause severe immunodeficiency in humans, characterised by impaired T- and B-lymphocyte differentiation, lymphocytopenia and diminished production of interleukin (IL)−6, tumour necrosis factor (TNF) and IL-12. Here, RIPK1 is linked to immunodeficiency disease.